These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21056063)

  • 1. Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats.
    Weston-Green K; Huang XF; Deng C
    Behav Brain Res; 2011 Mar; 217(2):337-46. PubMed ID: 21056063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
    Lian J; Deng C
    Pharmacol Biochem Behav; 2020 Apr; 191():172878. PubMed ID: 32112786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parametric analysis of olanzapine-induced weight gain in female rats.
    Cooper GD; Pickavance LC; Wilding JP; Halford JC; Goudie AJ
    Psychopharmacology (Berl); 2005 Aug; 181(1):80-9. PubMed ID: 15778884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Deng C
    PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
    Fell MJ; Marshall KM; Williams J; Neill JC
    J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
    Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
    Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.
    Davey KJ; Cotter PD; O'Sullivan O; Crispie F; Dinan TG; Cryan JF; O'Mahony SM
    Transl Psychiatry; 2013 Oct; 3(10):e309. PubMed ID: 24084940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of olanzapine on behavioural expression including the behavioural satiety sequence in female rats.
    Cooper GD; Goudie AJ; Halford JC
    J Psychopharmacol; 2010 Jul; 24(7):1069-78. PubMed ID: 19329550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
    Davoodi N; Kalinichev M; Korneev SA; Clifton PG
    Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term olanzapine treatment on meal-induced insulin sensitization and on gastrointestinal peptides in female Sprague-Dawley rats.
    Hegedűs C; Kovács D; Kiss R; Sári R; Németh J; Szilvássy Z; Peitl B
    J Psychopharmacol; 2015 Dec; 29(12):1271-9. PubMed ID: 26349558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
    Weston-Green K; Huang XF; Lian J; Deng C
    Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
    Horska K; Kucera J; Drazanova E; Kuzminova G; Amchova P; Hrickova M; Ruda-Kucerova J; Skrede S
    Biomed Pharmacother; 2024 Jul; 176():116763. PubMed ID: 38805968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
    Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
    Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.